par Abramowicz, Daniel 
;Norman, Douglas;Vereerstraeten, Pierre ;Goldman, Michel ;De Pauw, Luc ;Vanherweghem, Jean-Louis ;Kinnaert, Paul ;Kahana, Lawrence;Stuart, F.-P.;Thistlethwaite, Jr Richard;Shield, CF;Monaco, A.-P.;Wu, S.-C.;Haverty, T.-P.
Référence Kidney International, 49, page (768-772)
Publication Publié, 1996
;Norman, Douglas;Vereerstraeten, Pierre ;Goldman, Michel ;De Pauw, Luc ;Vanherweghem, Jean-Louis ;Kinnaert, Paul ;Kahana, Lawrence;Stuart, F.-P.;Thistlethwaite, Jr Richard;Shield, CF;Monaco, A.-P.;Wu, S.-C.;Haverty, T.-P.Référence Kidney International, 49, page (768-772)
Publication Publié, 1996
Article révisé par les pairs
| Titre: |
|
| Auteur: | Abramowicz, Daniel; Norman, Douglas; Vereerstraeten, Pierre; Goldman, Michel; De Pauw, Luc; Vanherweghem, Jean-Louis; Kinnaert, Paul; Kahana, Lawrence; Stuart, F.-P.; Thistlethwaite, Jr Richard; Shield, CF; Monaco, A.-P.; Wu, S.-C.; Haverty, T.-P. |
| Informations sur la publication: | Kidney International, 49, page (768-772) |
| Statut de publication: | Publié, 1996 |
| Sujet CREF: | Néphrologie - urologie |
| Hématologie | |
| Essais, contrôle médicaments | |
| MeSH keywords: | Adult |
| Cold Temperature | |
| Cyclosporine -- therapeutic use | |
| Female | |
| Follow-Up Studies | |
| Graft Rejection -- complications | |
| Graft Rejection -- epidemiology | |
| Graft Rejection -- prevention & control | |
| Graft Survival | |
| Humans | |
| Immunosuppressive Agents -- therapeutic use | |
| Incidence | |
| Ischemia | |
| Kidney Transplantation -- immunology | |
| Male | |
| Muromonab-CD3 -- therapeutic use | |
| Organ Preservation -- methods | |
| Prospective Studies | |
| Time Factors | |
| Note générale: | Clinical Trial |
| Journal Article | |
| Multicenter Study | |
| Randomized Controlled Trial | |
| Research Support, Non-U.S. Gov't | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0085-2538 |
| info:pmid/8648918 | |
| jlv-0108 |
